Mexico - North America Oligonucleotide Synthesis Market Size & Outlook
The oligonucleotide synthesis market in Mexico - North America is expected to reach a projected revenue of US$ 43.0 million by 2033. A compound annual growth rate of 12% is expected of Mexico - North America oligonucleotide synthesis market from 2026 to 2033.
Revenue, 2025 (US$M)
$17.7
Estimate, 2026 (US$M)
$19.5
Forecast, 2033 (US$M)
$43.0
CAGR, 2026 - 2033
12.0%
Global Market
Related Markets
Mexico oligonucleotide synthesis market highlights
- The Mexico oligonucleotide synthesis market generated a revenue of USD 17.7 million in 2025 and is expected to reach USD 43.0 million by 2033.
- The Mexico market is expected to grow at a CAGR of 12% from 2026 to 2033.
- In terms of segment, services was the largest revenue generating product in 2025.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
Oligonucleotide synthesis market data book summary
| Market revenue in 2025 | USD 17.7 million |
| Market revenue in 2033 | USD 43.0 million |
| Growth rate | 12% (CAGR from 2026 to 2033) |
| Largest segment | Services |
| Fastest growing segment | Services |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Oligonucleotides, Equipment/Synthesizer, Reagents, Services |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, GE HealthCare Technologies Inc Common Stock, Agilent Technologies, Kaneka Corp, Heritage Global Inc, Twist Bioscience Corp, Bio-Synthesis, Biolegio |
Other key industry trends
- In terms of revenue, Mexico accounted for 0.5% of the global oligonucleotide synthesis market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. oligonucleotide synthesis market is projected to lead the regional market in terms of revenue in 2033.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 3,872.1 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Oligonucleotide Synthesis Market Scope
Oligonucleotide Synthesis Market segmentation & scope
Oligonucleotide Synthesis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| GE HealthCare Technologies Inc Common Stock | View profile | 51,000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | www.gehealthcare.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Agilent Technologies | View profile | 10001+ | Santa Clara, California, United States, North America | www.agilent.com |
| Kaneka Corp | View profile | 13,284 | 3-2-4, Nakanoshima, Kita-ku, Osaka, Japan, 530-8288 | www.kaneka.co.jp |
| Heritage Global Inc | View profile | 82 | 12625 High Bluff Drive, Suite 305, San Diego, CA, United States, 92130 | www.hginc.com |
| Twist Bioscience Corp | View profile | 919 | 681 Gateway Boulevard, South San Francisco, CA, United States, 94080 | www.twistbioscience.com |
| Bio-Synthesis | View profile | 11-50 | Seminole, Texas, United States, North America | www.biosyn.com |
| Biolegio | View profile | 11-50 | Nijmegen, Gelderland, The Netherlands, Europe | www.biolegio.com |
Mexico - North America Oligonucleotide Synthesis Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Oligonucleotide Synthesis Market Outlook will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 42.94% in 2025.
Horizon Databook has segmented the Mexico - North America oligonucleotide synthesis market based on oligonucleotides, equipment/synthesizer, reagents, services covering the revenue growth of each sub-segment from 2021 to 2033.
- Mexico - North America Oligonucleotide Synthesis Market Product Outlook (Revenue, USD Million , 2021-2033)
- Oligonucleotides
- Equipment/Synthesizer
- Reagents
- Services
- Mexico - North America Oligonucleotide Synthesis Market Application Outlook (Revenue, USD Million , 2021-2033)
- PCR Primers
- PCR Assays and Panels
- Sequencing
- DNA Microarrays
- Fluorescence In Situ Hybridization (FISH)
- Antisense Oligonucleotides
- Other Applications
- Mexico - North America Oligonucleotide Synthesis Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical - Biotechnology Companies
Reasons to subscribe to Oligonucleotide Synthesis Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Oligonucleotide Synthesis Market Outlook databook
- Our clientele includes a mix of Oligonucleotide Synthesis Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico - North America Oligonucleotide Synthesis Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Mexico - North America Oligonucleotide Synthesis Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Mexico - North America Oligonucleotide Synthesis Market, 2021-2033 (US$M)
Mexico oligonucleotide synthesis market statistics, by product, 2021-2033 (US$M)
